Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

AI Robot Massages Enter the Spa Scene, Challenging Traditional Therapists

by Team Lumida
July 14, 2025
in Health and Longevity
Reading Time: 4 mins read
A A
0
AI Robot Massages Enter the Spa Scene, Challenging Traditional Therapists
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  1. Emerging Technology: AI-powered robot massage machines, such as Aescape, are being introduced in hotels and spas, including the W Scottsdale, Four Seasons Resort Orlando, and Ritz-Carlton Bacara.
  2. Automated Experience: The robot massage offers an automated experience with customizable settings for pressure and music, controlled via an iPad-like device.
  3. Comparison to Human Massage: A direct comparison at the W Scottsdale revealed that while the robot provided relaxation and convenience (no oils, no check-out), it lacked the personalized touch and ability to address specific areas like the head and neck, which a human therapist could.
  4. Cost Difference: A 60-minute Aescape robot massage cost $120*, significantly less than a 50-minute traditional de-stress massage at $190* (or$228 with service charge).
  5. Target Audience: Hotel general managers suggest robot massages are not meant to replace human therapists but cater to those who prefer less personal interaction or need quick recovery sessions, such as athletes.

What Happened?

A new trend in the spa industry sees the introduction of AI-powered robot massage machines, exemplified by Aescape, now available in several high-end hotels and spas. A Wall Street Journal columnist experienced both a robot massage and a traditional human massage at the W Scottsdale to compare the two.

The robot massage offered an automated, customizable experience, but the columnist found it less effective for specific pain points and lacking the comprehensive touch of a human therapist. Despite the cost difference, the human massage was deemed superior for its personalized approach and ability to address all body areas.


Why It Matters?

The emergence of AI robot massages signifies the increasing integration of artificial intelligence into service industries, including wellness and hospitality. This trend presents both opportunities for efficiency and challenges to traditional service models.

While robot massages offer a more affordable and potentially less intrusive option for some, they highlight the enduring value of human touch, intuition, and personalized care in services like massage therapy. The comparison underscores that while AI can automate tasks, it may not fully replicate the nuanced experience provided by human professionals.


What’s Next?

The adoption of AI robot massages is likely to continue, particularly in settings where quick, customizable, and less expensive options are desired. However, human massage therapists are unlikely to be fully replaced, as their ability to provide tailored, empathetic, and comprehensive treatments remains a key differentiator.

The future of the spa industry may see a hybrid model, where both AI-powered and human-led services coexist, catering to diverse client preferences and needs.


Source
Previous Post

Nvidia CEO Jensen Huang Dismisses Concerns Over Chinese Military Use of US AI Chips

Next Post

Wall Street Unfazed by Trump’s 200% Pharma Tariffs Due to Extended Grace Period

Recommended For You

AI-Discovered Drug Reverses Biological Aging by Up to 6 Years in Mid-Stage Trial, Nature Biotechnology Study Finds

by Team Lumida
1 week ago
AI Investment Boom: How Tech Giants Are Leading the Charge

Insilico Medicine's rentosertib — an AI-designed lung disease drug — reduced biological age by up to six years in a 42-patient mid-stage trial, per a Nature Biotechnology study,...

Read more

Oura Faces Class-Action Over Sleep Data Accuracy — And the Whole Wearables Industry Is Watching

by Team Lumida
1 week ago
person clicking Apple Watch smartwatch

A proposed class-action lawsuit alleges Oura's ring failed to reliably track sleep — raising questions about the gap between wearable health trackers' marketing promises and what their data...

Read more

Employer Healthcare Costs Projected to Rise 9.5% in 2027 — Fourth Consecutive Year of Near-Double-Digit Increases

by Team Lumida
2 weeks ago
doctor holding red stethoscope

Average healthcare costs are projected to reach more than $19,000 per employee in 2027, a 9.5% year-over-year increase, according to Aon. This marks the fourth consecutive year of...

Read more

US Alcohol Consumption Holds at Historic Low as Majority of Americans Now Say Drinking Is Bad for Health

by Team Lumida
4 weeks ago
clear drinking glass with ice cubes

A Gallup poll of 1,200 adults finds 54% of Americans consume alcohol — matching last year's historic low and halting three consecutive annual declines — while 51% now...

Read more

Big Food’s GLP-1 Reckoning: Conagra, Kraft, and Packaged-Food Giants Reformulate for the Not-So-Hungry

by Team Lumida
4 weeks ago
pasta with red sauce on white ceramic round plate

As GLP-1 weight-loss drugs suppress appetite across millions of households, packaged-food companies are retooling recipes, portion sizes, and sensory profiles to win over consumers who eat less but...

Read more

Novo Nordisk Tests Low-Dose Wegovy Pills as Most Patients Already Stick to Smallest Doses

by Team Lumida
4 weeks ago
Novo Nordisk Q2 2024 Earnings Highlights

Novo Nordisk has launched a 450-person trial to determine the minimum effective dose of its oral Wegovy pill — a clinically significant shift given that more than two-thirds...

Read more

4 in 5 Americans Say Healthcare Costs Are the Nation’s Top Health Problem — and Nobody Agrees on Who Should Fix It

by Team Lumida
4 weeks ago
doctor holding red stethoscope

A Commonwealth Fund survey of 25,873 adults finds near-universal alarm over health insurance premiums and out-of-pocket costs, even as ACA marketplace premiums surge 58% in 2026 and nearly...

Read more

Wealthy, Healthy, and Ready to Spend: Baby Boomers Are Driving a Global Travel Boom the Industry Is Racing to Serve

by Team Lumida
1 month ago
couple kissing on the road during daytime

Baby boomers — flush with retirement savings and in better health than previous generations — are fueling a high-end travel surge, with the industry responding with private-plane tours,...

Read more

385 Million Patient Records Breached and Counting — DentaQuest’s 15M-Person Hack Leads a New Wave of Healthcare Cybersecurity Disasters

by Team Lumida
1 month ago
person sitting while using laptop computer and green stethoscope near

The updated Healthcare Dive breach tracker reveals a sector in crisis: DentaQuest's 15M breach in 2026, Conduent's 62M in 2025, and Change Healthcare's record 192.7M in 2024.

Read more

Healthcare Stocks Are Now an Implicit AI Short — Semiconductors and Pharma Have Flipped to Negative Correlation

by Team Lumida
1 month ago
turned on monitoring screen

A structural shift is underway in equity markets: the VanEck Semiconductor ETF and the State Street Health Care ETF have moved into negative correlation, meaning healthcare has effectively...

Read more
Next Post
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Wall Street Unfazed by Trump’s 200% Pharma Tariffs Due to Extended Grace Period

a black square with a blue logo on it

Meta to Build Gigawatt-Scale Data Centers for AI Superintelligence, Pentagon Awards AI Contracts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Nvidia CEO Reveals Secrets Behind AI Domination Amidst Fierce Competition

Wall Street to AI Hyperscalers: Slow Down — $75B From Nvidia, SpaceX, and Amazon Is Testing the Bond Market’s Limits

July 13, 2026
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

JPMorgan, BofA, Wells Fargo Explore Buying Fiserv’s Debit Network to Sidestep Durbin Amendment Fee Caps

July 7, 2026
Geopolitical Forces Shape Oil Market Dynamics

Oil Hits $111 as Trump Reviews Iran’s Interim Deal Proposal — With Questions About Who Actually Submitted It

April 28, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018